Pharmaust completes Phase One Monepantel study and files for Orphan Drug Designation

Pharmaust (ASX:PAA) has announced that all patients have completed its phase one MEND study using monepantel…

Building Approvals up 7.5 per cent, CapEx also climbs

The number of dwelling approvals rose 7.5 per cent last month, in a big turn around…

Little Green Pharma’s strong half-year performance signals robust Cannabis growth in Europe and Australia

Little Green Pharma (ASX:LGP) released its half-yearly financial report, showing revenue from ordinary cannabis sales is…

4DMedical inks MOU with Philips to expand XV Technology sales in North America

4DMedical (ASX:4DX) has signed a MOU with Philips to expand sales opportunities for its XV Technology…
The Market Herald Video

Orcoda ranks 54th in Australian Financial Review’s prestigious Fast 100 list

Orcoda (ASX:ODA) has made the Australian Financial Review's Fast 100 list for 2023, ranked the 54th…

Metagenics USA launches MetaSleep powered by The Calmer Co’s Kavaton extract

The Calmer Co International (ASX:CCO) has supplied its Kavaton extract to leading US practitioner supplements brand,…
The Market Herald Video

TMH Market Close: ASX200 finishes up 0.4pc as Plenti soars on NAB EV loan deal

The ASX200 has closed up about .4 of a per cent, with just energy, IT, industrials…

Imugene shares soar as FDA grants fast-track designation for cancer-killing drug, Vaxinia

Imugene (ASX:IMU) has reached a milestone in its MAST clinical program using its novel cancer-killing virus,…
The Market Herald Video

TMH Market Update: ASX200 retreats, Adore Beauty rebuffs bid, Liontown completes SPP

The ASX200 has been trading down more than .4 per of a per cent today.   

EMVision unveils first point-of-care brain scanner device at RSNA 2023

EMVision Medical Devices (ASX:EMV) has revealed the name of its inaugural point-of-care brain scanner device, 'emu',…